STERIS plc

NYSE:STE Stock Report

Market Cap: US$23.9b

STERIS Balance Sheet Health

Financial Health criteria checks 5/6

STERIS has a total shareholder equity of $7.0B and total debt of $1.9B, which brings its debt-to-equity ratio to 27.3%. Its total assets and total liabilities are $10.4B and $3.4B respectively. STERIS's EBIT is $1.0B making its interest coverage ratio 16. It has cash and short-term investments of $279.7M.

Key information

27.30%

Debt to equity ratio

US$1.90b

Debt

Interest coverage ratio16x
CashUS$279.70m
EquityUS$6.97b
Total liabilitiesUS$3.44b
Total assetsUS$10.41b

Recent financial health updates

Recent updates

Calculating The Fair Value Of STERIS plc (NYSE:STE)

Aug 28
Calculating The Fair Value Of STERIS plc (NYSE:STE)

Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy

Aug 17

STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year

Aug 07
STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year

Is There Now An Opportunity In STERIS plc (NYSE:STE)?

Jul 06
Is There Now An Opportunity In STERIS plc (NYSE:STE)?

Is Now The Time To Put STERIS (NYSE:STE) On Your Watchlist?

May 23
Is Now The Time To Put STERIS (NYSE:STE) On Your Watchlist?

Is There An Opportunity With STERIS plc's (NYSE:STE) 33% Undervaluation?

May 07
Is There An Opportunity With STERIS plc's (NYSE:STE) 33% Undervaluation?

Is STERIS (NYSE:STE) A Risky Investment?

Apr 19
Is STERIS (NYSE:STE) A Risky Investment?

Risks To Shareholder Returns Are Elevated At These Prices For STERIS plc (NYSE:STE)

Apr 01
Risks To Shareholder Returns Are Elevated At These Prices For STERIS plc (NYSE:STE)

Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'

Mar 22

Is Now An Opportune Moment To Examine STERIS plc (NYSE:STE)?

Feb 06
Is Now An Opportune Moment To Examine STERIS plc (NYSE:STE)?

STERIS plc (NYSE:STE) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jan 19
STERIS plc (NYSE:STE) Shares Could Be 41% Below Their Intrinsic Value Estimate

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Jan 01
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Dec 14
STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Nov 18

What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Oct 19
What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16
User avatar

Robust Revenue Growth And Expanding Margins In The Medical Equipment Sector

Strong start to the fiscal year and gross margin improvements suggest underappreciated growth momentum and potential for expanding net margins.

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

Steris: Moving On, Losing Its Teeth

Apr 14

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

Financial Position Analysis

Short Term Liabilities: STE's short term assets ($2.1B) exceed its short term liabilities ($926.6M).

Long Term Liabilities: STE's short term assets ($2.1B) do not cover its long term liabilities ($2.5B).


Debt to Equity History and Analysis

Debt Level: STE's net debt to equity ratio (23.3%) is considered satisfactory.

Reducing Debt: STE's debt to equity ratio has reduced from 30.3% to 27.3% over the past 5 years.

Debt Coverage: STE's debt is well covered by operating cash flow (66.4%).

Interest Coverage: STE's interest payments on its debt are well covered by EBIT (16x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 12:24
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

STERIS plc is covered by 26 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Michael PolarkBaird
Erin Wilson WrightBofA Global Research